Ando M - Search Results

1

Pleuroparenchymal fibroelastosis in mycobacterium avium complex lung disease.

Sugino K, Ono H, Ando M, Tsuboi E. Sugino K, et al. Among authors: ando m. Respirol Case Rep. 2023 Jan 10;11(2):e01084. doi: 10.1002/rcr2.1084. eCollection 2023 Feb. Respirol Case Rep. 2023. PMID: 36636333 Free PMC article.

2

Autoimmune pulmonary alveolar proteinosis presenting peripheral ground-glass opacities.

Sugino K, Ando M, Mori K, Tsuboi E. Sugino K, et al. Among authors: ando m. Respirol Case Rep. 2018 Nov 13;7(1):e00385. doi: 10.1002/rcr2.385. eCollection 2019 Jan. Respirol Case Rep. 2018. PMID: 30459948 Free PMC article.

3

Miliary opacities in pulmonary sarcoidosis.

Sugino K, Ono H, Ando M, Igarashi S, Kurosaki A, Tsuboi E. Sugino K, et al. Among authors: ando m. Respirol Case Rep. 2020 Apr 18;8(5):e00563. doi: 10.1002/rcr2.563. eCollection 2020 Jul. Respirol Case Rep. 2020. PMID: 32313657 Free PMC article.

4

Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia.

Sugino K, Ono H, Shimizu H, Kurosawa T, Matsumoto K, Ando M, Mori K, Tsuboi E, Homma S, Kishi K. Sugino K, et al. Among authors: ando m. ERJ Open Res. 2021 Mar 1;7(1):00196-2020. doi: 10.1183/23120541.00196-2020. eCollection 2021 Jan. ERJ Open Res. 2021. PMID: 33681342 Free PMC article.

5

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis.

Sugino K, Ono H, Watanabe N, Ando M, Tsuboi E, Homma S, Kishi K. Sugino K, et al. Among authors: ando m. BMC Pulm Med. 2021 Jul 10;21(1):218. doi: 10.1186/s12890-021-01595-3. BMC Pulm Med. 2021. PMID: 34246227 Free PMC article.

6

Multiple endotracheal metastases of combined small cell lung carcinoma.

Sugino K, Ono H, Ando M, Kobayashi M, Igarashi S, Tsuboi E. Sugino K, et al. Among authors: ando m. Respirol Case Rep. 2022 Jun 9;10(7):e0986. doi: 10.1002/rcr2.986. eCollection 2022 Jul. Respirol Case Rep. 2022. PMID: 35702691 Free PMC article.

7

Coronavirus disease 2019 vaccination-induced acute exacerbation in idiopathic pulmonary fibrosis.

Sugino K, Ono H, Saito M, Ando M, Tsuboi E. Sugino K, et al. Among authors: ando m. Respirol Case Rep. 2022 Oct 12;10(11):e01051. doi: 10.1002/rcr2.1051. eCollection 2022 Nov. Respirol Case Rep. 2022. PMID: 36254333 Free PMC article.

8

Successful baricitinib treatment of refractory anti-synthetase syndrome associated with interstitial lung disease.

Sugino K, Ono H, Saito M, Ando M, Tsuboi E. Sugino K, et al. Among authors: ando m. Respirol Case Rep. 2023 Mar 22;11(4):e01129. doi: 10.1002/rcr2.1129. eCollection 2023 Apr. Respirol Case Rep. 2023. PMID: 36970295 Free PMC article.

9

Tolerability and efficacy of switching anti-fibrotic treatment from nintedanib to pirfenidone for idiopathic pulmonary fibrosis.

Sugino K, Ono H, Saito M, Ando M, Tsuboi E. Sugino K, et al. Among authors: ando m. PLoS One. 2024 Jun 13;19(6):e0305429. doi: 10.1371/journal.pone.0305429. eCollection 2024. PLoS One. 2024. PMID: 38870246 Free PMC article.

10

Resolution of Infliximab-Refractory Nivolumab-Induced Acute Severe Enterocolitis After Cyclosporine Treatment in a Patient with Non-Small Cell Lung Cancer.

Iyoda T, Kurita N, Takada A, Watanabe H, Ando M. Iyoda T, et al. Among authors: ando m. Am J Case Rep. 2018 Mar 27;19:360-364. doi: 10.12659/ajcr.908570. Am J Case Rep. 2018. PMID: 29581417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,483 results

Search Page

Filters